EMAIL THIS PAGE TO A FRIEND

Acta poloniae pharmaceutica

Simultaneous estimation of etoricoxib and thiocolchicoside by RP-HPLC method in combined dosage forms.


PMID 22125947

Abstract

A simple, reproducible and efficient reverse phase high performance liquid chromatographic method was developed for simultaneous estimation of etoricoxib and thiocolchicoside in combined tablet dosage form. Formulation containing etoricoxib and thiocolchicoside is used as analgesic. Chromatography was performed on a 250 mm x 4.6 mm, 5-microm particle size, BDS Hypersil C-18 column with trifluoroacetic acid buffer (pH 2.6) and acetonitrile (75:25, v/v) as a mobile phase. The detection of the combined dosage form was carried out at 220 nm and a flow rate employed was 1.5 mL/min. The retention times were 6.6 and 3.1 min for etoricoxib and thiocolchicoside, respectively. Linearity was obtained in the concentration range 20 to 160 ppm for etoricoxib and in the range 2 to 16 ppm for thiocolchicoside with a correlation coefficient of 0.9918 and 0.9994, respectively. The results of the analysis were validated statistically and recovery studies confirmed the accuracy and precision of the proposed method.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

32097
Etoricoxib, VETRANAL, analytical standard
C18H15ClN2O2S